ITU's 160 anniversary

Committed to connecting the world

  •  
Green digital action

ITU-T Recommendations

Search by number:
Others:
Skip Navigation Links
Content search
Advanced search
Provisional name
Equivalent number
Formal description
Study Groups tree viewExpand Study Groups tree view

ITU-T H.845.14 (04/2017)

عربي | 中文 | English | Español | Français | Русский
Conformance of ITU-T H.810 personal health system: Personal Health Devices interface Part 5N: International normalized ratio
Recommendation ITU-T H.845.14 provides a test suite structure (TSS) and the test purposes (TP) for devices measuring the international normalized ratio in Personal Health Devices (PHD) interface, based on the requirements defined in the Recommendations of the ITU-T H.810 sub-series, of which Recommendation ITU‑T H.810 (2016) is the base Recommendation. The objective of this test specification is to provide a high probability of interoperability at this interface.

Recommendation ITU-T H.845.14 is a transposition of Continua Test Tool DG2016, Test Suite Structure & Test Purposes, Personal Health Devices Interface; Part 5N: Device Specializations. Personal Health Device (International Normalized Ratio -INR-) (Version 1.3, 2016-09-20), that was developed by the Personal Connected Health Alliance. Versions of this specification existed before transposition and are indicated in Table 1.

This Recommendation includes an electronic attachment with the protocol implementation conformance statements (PICS) and the protocol implementation extra information for testing (PIXIT) required for the implementation of Annex A.
Citation: https://handle.itu.int/11.1002/1000/13231
Series title: H series: Audiovisual and multimedia systems
  H.800-H.899: E-health multimedia systems, services and applications
  H.820-H.859: Interoperability compliance testing of personal health systems (HRN, PAN, LAN, TAN and WAN)
Approval date: 2017-04-13
Provisional name:H.EH-PAN-05.14
Approval process:AAP
Status: In force
Maintenance responsibility: ITU-T Study Group 21
Further details: Patent statement(s)
Development history